John Soukar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
John Soukar has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Akhilesh Krishnakumar Gaharwar
Texas A&M University
5 shared publications - Vishal M. Gohil
Department of Biochemistry and Biophysics, Texas A&M University, College Station, USA
4 shared publications - Irtisha Singh
Department of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, USA
3 shared publications Anna Kersey
Department of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX 77843, USA
2 shared publications- Harman Kaur
Texas A&M University
2 shared publications - Kanwar Abhay Singh
Department of Biomedical Engineering College of Engineering Texas A&M University College Station Texas USA
2 shared publications
Latest Publications
- 30 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (44)
Augmenting intercellular mitochondrial transfer for tissue repair and rejuvenation
Cells exhibit innate reparative communication, enabling the exchange of bioactive molecules and, in some cases, entire organelles. Harnessing this endogenous process of intercellular organelle transfer represents an emerging therapeutic paradigm for restoring cellular function in diseases driven by organelle dysfunction. Mitochondrial transfer has gained prominence for its ability to restore bioenergetic capacity, mitigate oxidative stress, and rescue metabolic function in cells with impaired mitochondrial activity. Given that genetic or acquired defects in mitochondrial function are associated with diverse pathologies, including neurodegeneration, cardiovascular diseases, metabolic disorders, skeletal muscle defects, immune dysregulation, and age-associated decline, mitochondrial transfer offers broad therapeutic potential. Mitochondrial transfer seeks to deliver functional mitochondria to injured cells to reestablish metabolic competence. However, insufficient organelle trafficking and limited control over transfer dynamics remain critical barriers to clinical translation. Recent biotechnological developments aimed at enhancing donor-recipient connectivity, increasing mitochondrial availability, and modulating transfer machinery have begun to address some of these key challenges. This review highlights recent advances in mitochondrial transfer bioengineering, emerging therapeutic applications, and key challenges that must be resolved to enable clinical deployment.
- 30 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (44)
Augmenting intercellular mitochondrial transfer for tissue repair and rejuvenation
Cells exhibit innate reparative communication, enabling the exchange of bioactive molecules and, in some cases, entire organelles. Harnessing this endogenous process of intercellular organelle transfer represents an emerging therapeutic paradigm for restoring cellular function in diseases driven by organelle dysfunction. Mitochondrial transfer has gained prominence for its ability to restore bioenergetic capacity, mitigate oxidative stress, and rescue metabolic function in cells with impaired mitochondrial activity. Given that genetic or acquired defects in mitochondrial function are associated with diverse pathologies, including neurodegeneration, cardiovascular diseases, metabolic disorders, skeletal muscle defects, immune dysregulation, and age-associated decline, mitochondrial transfer offers broad therapeutic potential. Mitochondrial transfer seeks to deliver functional mitochondria to injured cells to reestablish metabolic competence. However, insufficient organelle trafficking and limited control over transfer dynamics remain critical barriers to clinical translation. Recent biotechnological developments aimed at enhancing donor-recipient connectivity, increasing mitochondrial availability, and modulating transfer machinery have begun to address some of these key challenges. This review highlights recent advances in mitochondrial transfer bioengineering, emerging therapeutic applications, and key challenges that must be resolved to enable clinical deployment.
- Open Access
- 13 August 2026
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (9) , 2441-2450
Copper Nanoparticles Enable Multi-Compartment Cuproenzyme Metalation in Cellular Models of Copper Deficiency
Copper (Cu) is an essential trace element that serves as a cofactor for enzymes involved in diverse metabolic pathways and processes across multiple subcellular compartments. Mutations that cause systemic or subcellular Cu deficiency result in fatal pediatric disorders, including Menkes disease and related mitochondrial disorders. Treatment of these disorders requires pharmacological agents that can transport Cu across membranes; however, the only approved drug, Cu histidinate, shows limited efficacy. Using genetic models of Menkes disease, we recently demonstrated that the Cu ionophore elesclomol (ES) efficiently restores the activity of mitochondrial and cytosolic cuproenzymes, but its ability to metalate cuproenzymes within secretory compartments is low. To overcome this limitation, we investigated Cu nanoparticles (Cu-NPs) as a facile means of delivering Cu to multiple subcellular compartments simultaneously. Cu-NPs were synthesized by chemical reduction to produce spherical nanoparticles with an average size of 80 nm. Biophysical characterization of Cu-NPs revealed zero-valent Cu and a neutral zeta potential, compatible with biological interactions and in vivo circulation. In cellular models of Cu deficiency, Cu-NPs were shown to internalize via clathrin-mediated endocytosis and restore the activity of cuproenzymes in mitochondrial, cytosolic, and secretory compartments. Importantly, biomarkers of Cu toxicity were not activated under these conditions, indicating a favorable therapeutic index. Overall, these findings highlight Cu-NPs as versatile Cu delivery agents with therapeutic potential for Cu deficiency disorders.
- 13 August 2026
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (9) , 2441-2450
Open AccessCopper Nanoparticles Enable Multi-Compartment Cuproenzyme Metalation in Cellular Models of Copper Deficiency
Copper (Cu) is an essential trace element that serves as a cofactor for enzymes involved in diverse metabolic pathways and processes across multiple subcellular compartments. Mutations that cause systemic or subcellular Cu deficiency result in fatal pediatric disorders, including Menkes disease and related mitochondrial disorders. Treatment of these disorders requires pharmacological agents that can transport Cu across membranes; however, the only approved drug, Cu histidinate, shows limited efficacy. Using genetic models of Menkes disease, we recently demonstrated that the Cu ionophore elesclomol (ES) efficiently restores the activity of mitochondrial and cytosolic cuproenzymes, but its ability to metalate cuproenzymes within secretory compartments is low. To overcome this limitation, we investigated Cu nanoparticles (Cu-NPs) as a facile means of delivering Cu to multiple subcellular compartments simultaneously. Cu-NPs were synthesized by chemical reduction to produce spherical nanoparticles with an average size of 80 nm. Biophysical characterization of Cu-NPs revealed zero-valent Cu and a neutral zeta potential, compatible with biological interactions and in vivo circulation. In cellular models of Cu deficiency, Cu-NPs were shown to internalize via clathrin-mediated endocytosis and restore the activity of cuproenzymes in mitochondrial, cytosolic, and secretory compartments. Importantly, biomarkers of Cu toxicity were not activated under these conditions, indicating a favorable therapeutic index. Overall, these findings highlight Cu-NPs as versatile Cu delivery agents with therapeutic potential for Cu deficiency disorders.
- Open Access
- 24 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (43)
Nanomaterial-induced mitochondrial biogenesis enhances intercellular mitochondrial transfer efficiency
Intercellular mitochondrial transfer, the spontaneous exchange of mitochondria between cells, is a recently described phenomenon crucial for cellular repair, regeneration, and disease management. Enhancing this natural process holds promise for developing novel therapies targeting diseases associated with mitochondrial dysfunction. Here, we introduce a nanomaterial-based approach employing molybdenum disulfide (MoS 2 ) nanoflowers with atomic-scale vacancies to stimulate mitochondrial biogenesis in cells to make them mitochondrial biofactories. Upon cellular uptake, these nanoflowers result in a two-fold increase in mitochondrial mass and enhancing mitochondrial transfer to recipient cells by several-fold. This enhanced efficiency of transfer significantly improves mitochondrial respiratory capacity and adenosine triphosphate production in recipient cells under physiological conditions. In cellular models of mitochondrial and cellular damage, MoS 2 enhanced mitochondrial transfer achieved remarkable restoration of cell function. This proof-of-concept study demonstrates that nanomaterial-boosted intercellular mitochondrial transfer can enhance cell survivability and function under diseased conditions, offering a promising strategy for treating mitochondrial dysfunction-related diseases.
- 24 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (43)
Open AccessNanomaterial-induced mitochondrial biogenesis enhances intercellular mitochondrial transfer efficiency
Intercellular mitochondrial transfer, the spontaneous exchange of mitochondria between cells, is a recently described phenomenon crucial for cellular repair, regeneration, and disease management. Enhancing this natural process holds promise for developing novel therapies targeting diseases associated with mitochondrial dysfunction. Here, we introduce a nanomaterial-based approach employing molybdenum disulfide (MoS 2 ) nanoflowers with atomic-scale vacancies to stimulate mitochondrial biogenesis in cells to make them mitochondrial biofactories. Upon cellular uptake, these nanoflowers result in a two-fold increase in mitochondrial mass and enhancing mitochondrial transfer to recipient cells by several-fold. This enhanced efficiency of transfer significantly improves mitochondrial respiratory capacity and adenosine triphosphate production in recipient cells under physiological conditions. In cellular models of mitochondrial and cellular damage, MoS 2 enhanced mitochondrial transfer achieved remarkable restoration of cell function. This proof-of-concept study demonstrates that nanomaterial-boosted intercellular mitochondrial transfer can enhance cell survivability and function under diseased conditions, offering a promising strategy for treating mitochondrial dysfunction-related diseases.
- Open Access
- 4 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (27) , eado1223
Nanosilicates promote angiogenesis through activation of ROS-mediated WNT/β-catenin pathway
Scaffold vascularization plays a pivotal role in the wound healing process, facilitating the recruitment of endogenous progenitor cells and delivering crucial signaling molecules that promote cellular invasion, angiogenesis, and neotissue formation. In this study, we introduce nanosilicates as proangiogenic biomaterials that can prime endogenous cells to expedite angiogenesis and graft vascularization in vivo. Characterized by their mineral-based two-dimensional structure and extensive surface area, nanosilicates are efficiently internalized by endothelial cells, leading to augmented cellular migration and the formation of tubular structures. Through whole transcriptome sequencing, we elucidated that nanosilicates activate the canonical Wnt pathway through hypoxia-induced ROS production. In vivo investigations further corroborate the proangiogenic efficacy of nanosilicate-loaded biomaterials. This study posits nanosilicates as a potential proangiogenic adjunct in the design of biomaterials for in situ tissue regeneration.
- 4 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (27) , eado1223
Open AccessNanosilicates promote angiogenesis through activation of ROS-mediated WNT/β-catenin pathway
Scaffold vascularization plays a pivotal role in the wound healing process, facilitating the recruitment of endogenous progenitor cells and delivering crucial signaling molecules that promote cellular invasion, angiogenesis, and neotissue formation. In this study, we introduce nanosilicates as proangiogenic biomaterials that can prime endogenous cells to expedite angiogenesis and graft vascularization in vivo. Characterized by their mineral-based two-dimensional structure and extensive surface area, nanosilicates are efficiently internalized by endothelial cells, leading to augmented cellular migration and the formation of tubular structures. Through whole transcriptome sequencing, we elucidated that nanosilicates activate the canonical Wnt pathway through hypoxia-induced ROS production. In vivo investigations further corroborate the proangiogenic efficacy of nanosilicate-loaded biomaterials. This study posits nanosilicates as a potential proangiogenic adjunct in the design of biomaterials for in situ tissue regeneration.
- Open Access
- 17 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Atomic vacancies of molybdenum disulfide nanoparticles stimulate mitochondrial biogenesis
Diminished mitochondrial function underlies many rare inborn errors of energy metabolism and contributes to more common age-associated metabolic and neurodegenerative disorders. Thus, boosting mitochondrial biogenesis has been proposed as a potential therapeutic approach for these diseases; however, currently we have a limited arsenal of compounds that can stimulate mitochondrial function. In this study, we designed molybdenum disulfide (MoS2) nanoflowers with predefined atomic vacancies that are fabricated by self-assembly of individual two-dimensional MoS2 nanosheets. Treatment of mammalian cells with MoS2 nanoflowers increased mitochondrial biogenesis by induction of PGC-1α and TFAM, which resulted in increased mitochondrial DNA copy number, enhanced expression of nuclear and mitochondrial-DNA encoded genes, and increased levels of mitochondrial respiratory chain proteins. Consistent with increased mitochondrial biogenesis, treatment with MoS2 nanoflowers enhanced mitochondrial respiratory capacity and adenosine triphosphate production in multiple mammalian cell types. Taken together, this study reveals that predefined atomic vacancies in MoS2 nanoflowers stimulate mitochondrial function by upregulating the expression of genes required for mitochondrial biogenesis.
- 17 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessAtomic vacancies of molybdenum disulfide nanoparticles stimulate mitochondrial biogenesis
Diminished mitochondrial function underlies many rare inborn errors of energy metabolism and contributes to more common age-associated metabolic and neurodegenerative disorders. Thus, boosting mitochondrial biogenesis has been proposed as a potential therapeutic approach for these diseases; however, currently we have a limited arsenal of compounds that can stimulate mitochondrial function. In this study, we designed molybdenum disulfide (MoS2) nanoflowers with predefined atomic vacancies that are fabricated by self-assembly of individual two-dimensional MoS2 nanosheets. Treatment of mammalian cells with MoS2 nanoflowers increased mitochondrial biogenesis by induction of PGC-1α and TFAM, which resulted in increased mitochondrial DNA copy number, enhanced expression of nuclear and mitochondrial-DNA encoded genes, and increased levels of mitochondrial respiratory chain proteins. Consistent with increased mitochondrial biogenesis, treatment with MoS2 nanoflowers enhanced mitochondrial respiratory capacity and adenosine triphosphate production in multiple mammalian cell types. Taken together, this study reveals that predefined atomic vacancies in MoS2 nanoflowers stimulate mitochondrial function by upregulating the expression of genes required for mitochondrial biogenesis.
- 9 May 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology
- Vol. 6 (3) , 420-428
Experimental Evidence of Radio Frequency Radiation From Staphylococcus aureus Biofilms
This paper reports the first successful detection of electromagnetic (EM) radiation from Staphylococcus aureus biofilms in the gigahertz (GHz) frequency range. Two novel sensing systems are deployed for the measurement. A very sensitive wideband near-zone radiative system specifically designed for this application is first used to search for signals in the 1–50 GHz frequency region. Notable radiation is observed in the 3–4 GHz band. Exposure to lethal doses of Zinc oxide nanopyramids (ZnO-NPY) is used to verify that the signals are indeed produced by living cells rather than material thermal emission. Afterwards, a spiral antenna system is exploited to further examine the band of interest in the near-field region. Radiation from 3 identical biofilm samples is monitored and recorded over 70 days. Two distinct frequency bands, namely the 3.18 GHz and the 3.45 GHz bands, are identified as potential “communication bands”. Furthermore, long-term and short-term cycles of the total radiation intensity within the band are observed over the course of the experiment. This work confirms the presence of EM radiation within bacterial communities, which is a key requirement to demonstrate EM signaling among bacterial cells. The insight could lead to breakthroughs in demystifying how cells communicate as well as advancement of important technologies in biology and communication systems.
- 9 May 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology
- Vol. 6 (3) , 420-428
Experimental Evidence of Radio Frequency Radiation From Staphylococcus aureus Biofilms
This paper reports the first successful detection of electromagnetic (EM) radiation from Staphylococcus aureus biofilms in the gigahertz (GHz) frequency range. Two novel sensing systems are deployed for the measurement. A very sensitive wideband near-zone radiative system specifically designed for this application is first used to search for signals in the 1–50 GHz frequency region. Notable radiation is observed in the 3–4 GHz band. Exposure to lethal doses of Zinc oxide nanopyramids (ZnO-NPY) is used to verify that the signals are indeed produced by living cells rather than material thermal emission. Afterwards, a spiral antenna system is exploited to further examine the band of interest in the near-field region. Radiation from 3 identical biofilm samples is monitored and recorded over 70 days. Two distinct frequency bands, namely the 3.18 GHz and the 3.45 GHz bands, are identified as potential “communication bands”. Furthermore, long-term and short-term cycles of the total radiation intensity within the band are observed over the course of the experiment. This work confirms the presence of EM radiation within bacterial communities, which is a key requirement to demonstrate EM signaling among bacterial cells. The insight could lead to breakthroughs in demystifying how cells communicate as well as advancement of important technologies in biology and communication systems.